Related references
Note: Only part of the references are listed.Subacute thyroiditis in a patient infected with SARS-COV-2: an endocrine complication linked to the COVID-19 pandemic
Rosaria Maddalena Ruggeri et al.
HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM (2021)
COVID-19 Pulmonary and Olfactory Dysfunctions: Is the Chemokine CXCL10 the Common Denominator?
Antonio Oliviero et al.
NEUROSCIENTIST (2021)
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Peng Zhou et al.
NATURE (2020)
Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2
Renhong Yan et al.
SCIENCE (2020)
Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2
Qihui Wang et al.
CELL (2020)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
ACE2 Expression in Pancreas May Cause Pancreatic Damage After SARS-CoV-2 Infection
Furong Liu et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)
The cytokine storm in COVID-19: An overview of the involvement of the chemokine/chemokine-receptor system
Francesca Coperchini et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2020)
Expression of SARS-CoV-2 receptor ACE2 and TMPRSS2 in human primary conjunctival and pterygium cell lines and in mouse cornea
Di Ma et al.
EYE (2020)
Subacute Thyroiditis After Sars-COV-2 Infection
Alessandro Brancatella et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)
Cytokine release syndrome in severe COVID-19
John B. Moore et al.
SCIENCE (2020)
ACE2 receptor polymorphism: Susceptibility to SARS-CoV-2, hypertension, multi-organ failure, and COVID-19 disease outcome
Christian A. Devaux et al.
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2020)
Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues
Meng-Yuan Li et al.
INFECTIOUS DISEASES OF POVERTY (2020)
SARS-CoV-2: a potential trigger for subacute thyroiditis? Insights from a case report
S. Ippolito et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2020)
Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection
Zou Xin et al.
FRONTIERS OF MEDICINE (2020)
Potential influence of COVID-19/ACE2 on the female reproductive system
Yan Jing et al.
MOLECULAR HUMAN REPRODUCTION (2020)
scRNA-seq Profiling of Human Testes Reveals the Presence of the ACE2 Receptor, A Target for SARS-CoV-2 Infection in Spermatogonia, Leydig and Sertoli Cells
Zhengpin Wang et al.
CELLS (2020)
The proximal origin of SARS-CoV-2
Kristian G. Andersen et al.
NATURE MEDICINE (2020)
Endocrine Significance of SARS-CoV-2's Reliance on ACE2
Eric Lazartigues et al.
ENDOCRINOLOGY (2020)
A case of subacute thyroiditis associated with Covid-19 infection
E. Asfuroglu Kalkan et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2020)
Is Subacute Thyroiditis an Underestimated Manifestation of SARS-CoV-2 Infection? Insights From a Case Series
Alessandro Brancatella et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)
Protease inhibitors targeting coronavirus and filovirus entry
Yanchen Zhou et al.
ANTIVIRAL RESEARCH (2015)
Tissue-based map of the human proteome
Mathias Uhlen et al.
SCIENCE (2015)
Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes
Jin-Kui Yang et al.
ACTA DIABETOLOGICA (2010)
Pathology of the thyroid in severe acute respiratory syndrome
Lan Wei et al.
HUMAN PATHOLOGY (2007)
Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis
I Hamming et al.
JOURNAL OF PATHOLOGY (2004)
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
WH Li et al.
NATURE (2003)
Angiotensin-I-converting enzyme and its relatives
JF Riordan
GENOME BIOLOGY (2003)
ACEH/ACE2 is a novel mammalian metallocarboxypeptidase and a homologue of angiotensin-converting enzyme insensitive to ACE inhibitors
AJ Turner et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2002)
Share Paper
